BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 23823969)

  • 1. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
    Nazim SM; Raza SJ; Ather MH
    J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer screening attitudes and continuing education needs of primary care physicians.
    Curran V; Solberg S; Mathews M; Church J; Buehler S; Wells J; Lopez T
    J Cancer Educ; 2005; 20(3):162-6. PubMed ID: 16122364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Focus on the screening for prostate cancer by PSA].
    Roumeguère T; Van Velthoven R
    Rev Med Brux; 2013 Sep; 34(4):311-9. PubMed ID: 24195246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes and beliefs of primary care physicians regarding prostate and colorectal cancer screening in a rural state.
    Philips GK; Reinier K; Ashikaga T; Luebbers RA
    J Cancer Educ; 2005; 20(3):167-72. PubMed ID: 16122365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [When and how to prescribe PSA?].
    Coloby P
    Rev Prat; 2013 Apr; 63(4):476-7. PubMed ID: 23682471
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of digital rectal examination and prostate specific antigen in detecting carcinoma prostate.
    Iqbal N; Bhatti AN; Husain S
    J Coll Physicians Surg Pak; 2003 Jun; 13(6):340-2. PubMed ID: 12814533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels.
    Yoo DS; Woo SH; Cho S; Kang SH; Kim SJ; Park SY; Lee SH; Jeon SH; Park J
    Urology; 2014 Jun; 83(6):1339-43. PubMed ID: 24726151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
    Malli G
    Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
    Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
    Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].
    Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):16-8. PubMed ID: 18346372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
    Palmerola R; Smith P; Elliot V; Reese CT; Mahon FB; Harpster LE; Icitovic N; Raman JD
    Can J Urol; 2012 Dec; 19(6):6542-7. PubMed ID: 23228289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
    Presti JC; Hovey R; Carroll PR; Shinohara K
    J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline of guidelines: prostate cancer screening.
    Loeb S
    BJU Int; 2014 Sep; 114(3):323-5. PubMed ID: 24981126
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of lowering the prostate-specific antigen normal cutoff on referral rates to urology.
    Shenker BS; Stern J
    J Am Board Fam Med; 2012; 25(6):927-9. PubMed ID: 23136335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening: a survey of attitudes and practices among Finnish physicians in 1999 and 2007.
    Pogodin-Hannolainen D; Juusela H; Tammela TL; Ruutu M; Aro J; Määttänen L; Auvinen A
    J Med Screen; 2011; 18(1):46-9. PubMed ID: 21536817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.